会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 63. 发明授权
    • Headphones
    • 耳机
    • US08194910B2
    • 2012-06-05
    • US12454885
    • 2009-05-26
    • Hiroshi UchidaMakoto Ito
    • Hiroshi UchidaMakoto Ito
    • H04R25/00
    • H04R1/1091H04R1/1058H04R1/1075H04R5/033H04R2420/07
    • A headphone set has a housing to contain a speaker unit, with a sound emitting surface through which sounds given off by the speaker unit are emitted out, and an ear pad attached to the housing to surround the sound emitting surface. The ear pad has a protruding member and an arc-like member sticking out in opposite directions. The degree of sticking out for the arc-like member is smaller than the degree of sticking out for the protruding member. The protruding member has an inner space interposed between a top section and an opposing bottom section closer than the top section to the sound emitting section. The arc-like member has a top section and an opposing bottom section closer than the top section to the sound emitting surface. The top section of the protruding member is positioned farther than that of the arc-like member from the sound emitting surface.
    • 耳机组具有容纳扬声器单元的壳体,其具有通过扬声器单元发出的声音的声音发射表面,以及附接到壳体以围绕声音发射表面的耳垫。 该耳垫具有突出的构件和在相反方向上突出的弧状构件。 圆弧状部件伸出的程度小于伸出部件伸出的程度。 突出构件具有插入在顶部与相对于发声部的顶部更靠近的相对底部之间的内部空间。 弧形构件具有比发声表面的顶部更靠近的顶部部分和相对的底部部分。 突出构件的顶部位于远离发声表面的弧形构件的顶部。
    • 66. 发明申请
    • STABILIZED PHARMACEUTICAL COMPOSITION
    • 稳定的药物组合物
    • US20110152342A1
    • 2011-06-23
    • US13058641
    • 2009-08-14
    • Hiroshi UchidaMamoru FukudaSeigo Aritomi
    • Hiroshi UchidaMamoru FukudaSeigo Aritomi
    • A61K31/40
    • A61K31/40A61K9/2018A61K9/2081A61K9/2866A61K9/5015
    • A pharmaceutical composition is provided which can easily be prepared and which can prevent decomposition of an aminoacetylpyrrolidine carbonitrile derivative, as an effective component, which derivative is in general instable in a pharmaceutical composition.More specifically, the pharmaceutical composition comprises an aminoacetyl pyrrolidine carbonitrile derivative represented by the following general formula (1): (in the formula (1), A represents CH2, CHF or CF2; and R1 represents a secondary amino group which may have a substituent), and the following components blended with the derivative: (1) a sugar alcohol; (2) calcium carbonate, sodium citrate or sodium sulfate; and (3) a neutral low melting point oily and/or fatty substance.
    • 提供了一种药物组合物,其可以容易地制备并且可以防止氨基乙酰基吡咯烷腈衍生物作为有效成分的分解,该衍生物通常在药物组合物中不稳定。 更具体地,药物组合物包含由以下通式(1)表示的氨基乙酰基吡咯烷腈衍生物:(在式(1)中,A表示CH 2,CHF或CF 2; R 1表示可具有取代基的仲氨基 ),并且以下组分与衍生物混合:(1)糖醇; (2)碳酸钙,柠檬酸钠或硫酸钠; 和(3)中性低熔点油性和/或脂肪物质。